Financial Gaps Threaten Achievement Of 90-90-90 HIV Targets

The Conversation: It will take more than $36 billion every year to end AIDS
Charles Wiysonge, professor of clinical epidemiology at the Faculty of Medicine and Health Sciences at Stellenbosch University

“…Current epidemiological and financial trends suggest there’s a major risk of a substantial shortfall in the funds required to sustain life-saving antiretroviral programs. … UNAIDS and other international development agencies hope that the growing need for funding will be partly solved by expanded health spending in low-income countries. But the scarcity of adequate funds to provide antiretrovirals to people living with HIV — together with the possibility of rising drug resistance to existing antiretroviral treatments — will make achieving the goal to end AIDS by 2030 extremely difficult. … Meeting the needs of people living with HIV will require a combination of the following evidence-informed strategies: concentrating development assistance for HIV in these low-income countries; improving the efficiency of HIV programs; increasing domestic financing; lowering the cost of treatment (including the prices of antiretrovirals); and reducing future incidence through more concerted efforts…” (7/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.